Robert Roubey
About
Robert Roubey is a scholar working on Rheumatology, Hematology and Radiology, Nuclear Medicine and Imaging.
According to data from OpenAlex, Robert Roubey has authored 62 papers receiving a total of 3.4k indexed citations (citations by other indexed papers that have themselves been cited), including 51 papers in Rheumatology, 26 papers in Hematology and 18 papers in Radiology, Nuclear Medicine and Imaging. Recurrent topics in Robert Roubey's work include Systemic Lupus Erythematosus Research (47 papers), Platelet Disorders and Treatments (24 papers) and Monoclonal and Polyclonal Antibodies Research (18 papers). Robert Roubey is often cited by papers focused on Systemic Lupus Erythematosus Research (47 papers), Platelet Disorders and Treatments (24 papers) and Monoclonal and Polyclonal Antibodies Research (18 papers). Robert Roubey collaborates with scholars based in United States, Japan and Italy. Robert Roubey's co-authors include J B Winfield, Jill P. Buyon, Philip L. Cohen, Mark F. Harper, Robert A. Eisenberg, Alisa S. Wolberg, Roberto Caricchio, H. Shelton Earp, Glenn K. Matsushima and Elizabeth A. Reap and has published in prestigious journals such as The Lancet, Journal of Clinical Investigation and The Journal of Experimental Medicine.
In The Last Decade
Robert Roubey
62 papers receiving 3.3k citations
Hit Papers
Peers — A (Enhanced Table)
Peers by citation overlap · career bar shows stage (early→late) cites · hero ref
| Name | h | Career | Trend | Papers | Cites | |||||
|---|---|---|---|---|---|---|---|---|---|---|
| Robert Roubey United States | 29 | 2.3k | 1.3k | 1.2k | 748 | 380 | 62 | 3.4k | ||
| Graham Hughes United Kingdom | 22 | 2.8k 1.2× | 1.6k 1.3× | 673 0.6× | 611 0.8× | 268 0.7× | 49 | 3.8k | ||
| Shinsuke Yasuda Japan | 32 | 1.8k 0.8× | 993 0.8× | 1.1k 0.9× | 251 0.3× | 272 0.7× | 163 | 3.2k | ||
| Cheryl Yarboro United States | 31 | 3.3k 1.4× | 2.6k 2.0× | 596 0.5× | 848 1.1× | 290 0.8× | 51 | 5.3k | ||
| Sudha Visvanathan United States | 35 | 3.5k 1.5× | 2.5k 2.0× | 1.7k 1.4× | 414 0.6× | 405 1.1× | 71 | 5.4k | ||
| C.N. Chesterman Australia | 22 | 1.3k 0.6× | 467 0.4× | 1000 0.9× | 576 0.8× | 231 0.6× | 40 | 2.6k | ||
| Emese Kiss Hungary | 34 | 2.0k 0.9× | 1.2k 0.9× | 365 0.3× | 366 0.5× | 265 0.7× | 130 | 3.2k | ||
| R. H. W. M. Derksen Netherlands | 25 | 1.3k 0.6× | 619 0.5× | 544 0.5× | 568 0.8× | 154 0.4× | 41 | 1.9k | ||
| Enrique de Ramón Spain | 20 | 2.1k 0.9× | 1.3k 1.1× | 296 0.3× | 478 0.6× | 200 0.5× | 51 | 3.1k | ||
| Anna Filipowicz‐Sosnowska Poland | 8 | 1.8k 0.8× | 1.1k 0.8× | 588 0.5× | 798 1.1× | 137 0.4× | 36 | 3.4k | ||
| Andreas Jönsen Sweden | 37 | 2.6k 1.1× | 2.5k 2.0× | 339 0.3× | 638 0.9× | 372 1.0× | 105 | 3.9k |
Countries citing papers authored by Robert Roubey
Since
Specialization
Citations
This map shows the geographic impact of Robert Roubey's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Robert Roubey with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Robert Roubey more than expected).
Fields of papers citing papers by Robert Roubey
Since
Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences
This network shows the impact of papers produced by Robert Roubey. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Robert Roubey. The network helps show where Robert Roubey may publish in the future.
Co-authorship network of co-authors of Robert Roubey
This figure shows the co-authorship network connecting the top 25 collaborators of Robert Roubey. A scholar is included among the top collaborators of Robert Roubey based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Robert Roubey. Robert Roubey is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
1.
Meroni, Pier Luigi, María Orietta Borghi, O Amengual, et al.. (2024). 2023 American College of Rheumatology/European League Against Rheumatism antiphospholipid syndrome classification criteria solid phase–based antiphospholipid antibody domain—collaborative efforts of Antiphospholipid Syndrome Alliance for Clinical Trials and International Networking and ISTH SSC to harmonize enzyme-linked immunosorbent assay and non–enzyme-linked immunosorbent assay antiphospholipid antibody tests: communication from the ISTH SSC Subcommittee on Lupus Anticoagulant/Antiphospholipid Antibodies. Journal of Thrombosis and Haemostasis. 23(1). 341–344.
2.
Chighizola, Cecilia Beatrice, Rohan Willis, Gabriella Maioli, et al.. (2024). Deciphering the clinical significance of longitudinal antiphospholipid antibody titers. Autoimmunity Reviews. 23(3). 103510–103510.
3.
Atsumi, Tatsuya, Cecilia Beatrice Chighizola, Yuichiro Fujieda, et al.. (2023). 16th International congress on antiphospholipid antibodies task force report on antiphospholipid syndrome laboratory diagnostics and trends. Lupus. 32(14). 1625–1636.
4.
Erkan, Doruk, Savino Sciascia, María Laura Bertolaccini, et al.. (2021). Antiphospholipid Syndrome Alliance for Clinical Trials and International Networking (APS ACTION): 10-Year Update. Current Rheumatology Reports. 23(6).
5.
Erkan, Doruk, Savino Sciascia, María Laura Bertolaccini, et al.. (2021). Correction to: Antiphospholipid Syndrome Alliance for Clinical Trials and International Networking (APS ACTION): 10-Year Update. Current Rheumatology Reports. 23(7). 48–48.
6.
Fuentes, Rudy, Rebecca Subang, A. Hachem, et al.. (2015). Antiphospholipid antibody-mediated effects in an arterial model of thrombosis are dependent on Toll-like receptor 4. Lupus. 25(2). 162–176.
7.
Bertolaccini, María Laura, Olga Amengual, Laura Andréoli, et al.. (2014). 14th International Congress on Antiphospholipid Antibodies Task Force. Report on antiphospholipid syndrome laboratory diagnostics and trends. Autoimmunity Reviews. 13(9). 917–930.
8.
Bradford, Robert L., et al.. (2013). Plasma Microparticle Tissue Factor Activity in Patients With Antiphospholipid Antibodies With and Without Clinical Complications. Thrombosis Research. 133(2). 187–189.
9.
Desai, Rishi, Richard A. Hansen, Jaya K. Rao, et al.. (2012). Mixed Treatment Comparison of the Treatment Discontinuations of Biologic Disease-Modifying Antirheumatic Drugs in Adults with Rheumatoid Arthritis. Annals of Pharmacotherapy. 46(11). 1491–1505.
10.
Alexis, Neil E., W. June Brickey, John C. Lay, et al.. (2008). Development of an inhaled endotoxin challenge protocol for characterizing evoked cell surface phenotype and genomic responses of airway cells in allergic individuals. Annals of Allergy Asthma & Immunology. 100(3). 206–215.
11.
Wagner, James G., Qing Jiang, Jack R. Harkema, et al.. (2007). γ‐Tocopherol prevents airway eosinophilia and mucous cell hyperplasia in experimentally induced allergic rhinitis and asthma. Clinical & Experimental Allergy. 38(3). 501–511.
12.
Cohen, Philip L., Roberto Caricchio, Valsamma Abraham, et al.. (2002). Delayed Apoptotic Cell Clearance and Lupus-like Autoimmunity in Mice Lacking the c-mer Membrane Tyrosine Kinase. The Journal of Experimental Medicine. 196(1). 135–140.
13.
Roubey, Robert, et al.. (1996). Comparison of an enzyme‐linked immunosorbent assay for antibodies to β2‐glycoprotein I and a conventional anticardiolipin immunoassay. Arthritis & Rheumatism. 39(9). 1606–1607.
14.
Roubey, Robert. (1994). Antigenic specificities of ?antiphospholipid? autoantibodies. Springer Seminars in Immunopathology. 16(2-3). 211–22.
15.
Jarjour, Wael, Seiji Minota, Robert Roubey, Toshihide Mimura, & John B. Winfield. (1992). Autoantibodies to nucleolin cross-react with histone H1 in systemic Lupus erythematosus. Molecular Biology Reports. 16(4). 263–266.
16.
Roubey, Robert, Charlotte W. Pratt, Jill P. Buyon, & J B Winfield. (1992). Lupus anticoagulant activity of autoimmune antiphospholipid antibodies is dependent upon beta 2-glycoprotein I.. Journal of Clinical Investigation. 90(3). 1100–1104.
17.
Roubey, Robert, JT Merrill, Felecia S. Walton, et al.. (1991). Staurosporine inhibits neutrophil phagocytosis but not iC3b binding mediated by CR3 (CD11b/CD18). The Journal of Immunology. 146(10). 3557–3562.
18.
Reed, William, Robert Roubey, Barry L. Myones, et al.. (1990). Synthesis of complement component C5 by human B and T lymphoblastoid cell lines. Immunogenetics. 31(3). 145–151.
19.
Buyon, Jill P., Eldad Ben‐Chetrit, Sharon L. Karp, et al.. (1989). Acquired congenital heart block. Pattern of maternal antibody response to biochemically defined antigens of the SSA/Ro-SSB/La system in neonatal lupus.. Journal of Clinical Investigation. 84(2). 627–634.
20.
Buyon, Jill P., Robert Roubey, Lisa Pompeo, et al.. (1988). Complete congenital heart block: risk of occurrence and therapeutic approach to prevention.. PubMed. 15(7). 1104–8.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.
Explore authors with similar magnitude of impact
Breakdown of academic impact, for papers by Graham Hughes Breakdown of academic impact, for papers by Shinsuke Yasuda Breakdown of academic impact, for papers by Cheryl Yarboro Breakdown of academic impact, for papers by Sudha Visvanathan Breakdown of academic impact, for papers by C.N. Chesterman Breakdown of academic impact, for papers by Emese Kiss Breakdown of academic impact, for papers by R. H. W. M. Derksen Breakdown of academic impact, for papers by Enrique de Ramón Breakdown of academic impact, for papers by Anna Filipowicz‐Sosnowska Breakdown of academic impact, for papers by Andreas Jönsen